ArticleJournal of natural medicines2026
New cerebrosides from the polar starfish Leptasterias polaris acervata and their cardioprotective and anti-inflammatory activity.
Article in Journal of natural medicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Two new cerebrosides leptasteriacerebroside A (1) and B (2) were isolated from the starfish Leptasterias polaris acervata, together with two known ones (2S,3R,4E,9Z)-1-O-(β-D-glucopyranosyl)-2-[(2R)-2-hydroxyhexadecanoylamino]-4,9-docosadien-3-ol (3) and astrocerebroside B (4). The structures of the isolated compounds were characterized using spectroscopic techniques HRESIMS, ESIMS/MS, 1D and 2D NMR as well as by chemical modification and subsequent analysis of derivatives. The antimicrobial, urease inhibitory, cytotoxic, and cytoprotective activities of compounds 1–4 were investigated. Notably, compound 1 exhibited significant protection of H9c2 cardiomyocytes against CoCl2-induced toxicity, while compounds 2 and 4 demonstrated efficacy in mitigating TNF-α-mediated cytotoxicity, likely through inhibition of the NF-κB-dependent inflammatory pathway.
Indexed as
Identifiers
41634280What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.